Draper Esprit Aktie 30782172 / GB00BY7QYJ50
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
02.02.2026 08:00:05
|
Investor Day
|
Molten Ventures Plc (GROW)
2 February 2026 Molten Ventures plc Investor Day Molten Ventures (LSE: GROW), a leading venture capital firm investing in and developing high-growth digital technology businesses, is hosting its annual Investor Day for institutional investors, analysts, and other key investors and stakeholders on Wednesday, 11 February 2026.
As in previous years, the event will feature a number of keynote speakers from across the Molten portfolio and Molten investment team, providing greater insight and an opportunity to learn about current trends in technology across Europe. Ben Wilkinson, Chief Executive Officer, will also present an update on recent activity and priorities, key advancements in the sector, as well as celebrating a very special milestone: 20 years since Molten Ventures was founded and 10 years since IPO in June 2016.
The portfolio companies represented on the day will include Core Portfolio companies ICEYE and HiveMQ, along with Emerging Portfolio companies causaLens, Clue, General Index, IMU Biosciences, Manna, ModoEnergy, SatVu, and Settlemint.
No new material disclosures will be made during the event.
Company materials from the event will be made available shortly after the event on the Company’s website: https://investors.moltenventures.com/investor-relations/plc
To enquire about attending the event, please email ir@molten.vc.
Enquiries:
Molten Ventures is a leading venture capital firm in Europe, developing and investing in high growth technology companies. It invests across four sectors: Enterprise & SaaS; AI, Deeptech & Hardware; Consumer Technology; and Digital Health with highly experienced partners constantly looking for new opportunities in each. Listed on the London Stock Exchange, Molten Ventures provides a unique opportunity for public market investors to access these fast-growing tech businesses, without having to commit to long term investments with limited liquidity. Since its IPO in June 2016, Molten has deployed over £1bn capital into fast growing tech companies and has realised more than £700m to 30 September 2025. For more information, go to https://investors.moltenventures.com/investor-relations/plc Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. View original content: EQS News |
| ISIN: | GB00BY7QYJ50 |
| Category Code: | MSCL |
| TIDM: | GROW |
| LEI Code: | 213800IPCR3SAYJWSW10 |
| Sequence No.: | 416756 |
| EQS News ID: | 2269080 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Draper Esprit PLC
|
08:00 |
Transaction in Own Shares (EQS Group) | |
|
24.02.26 |
Transaction in Own Shares (EQS Group) | |
|
23.02.26 |
Transaction in Own Shares (EQS Group) | |
|
20.02.26 |
Transaction in Own Shares (EQS Group) | |
|
19.02.26 |
Transaction in Own Shares (EQS Group) | |
|
18.02.26 |
Transaction in Own Shares (EQS Group) | |
|
17.02.26 |
Transaction in Own Shares (EQS Group) | |
|
17.02.26 |
Appointment of Joint Financial Adviser and Corporate Broker (EQS Group) |
Longevity = mehr Rendite? Dr. Anna Erat über Healthspan & Investments – zu Gast im BX Morningcall
Im neuesten BX Morningcall ist Dr. Anna Erat zu Gast – Spezialistin für Innere Medizin, Sportmedizin, Prävention und Longevity. Gemeinsam mit Olivia Hähnel und François Bloch sprechen wir darüber, was Longevity wirklich bedeutet (Healthspan vs. Lifespan), warum es mehr ist als Biohacking und wie man seriöse Angebote von Hype unterscheidet.
Dr. Erat gibt Einblick, wie eine erste Longevity-Konsultation abläuft, welche Rolle Anamnese, Genetik/Epigenetik und Technologie/AI spielen und worauf Patientinnen und Patienten bei der Wahl eines Anbieters achten sollten. Ausserdem: Versicherung & Kostenübernahme in der Schweiz, Erwartungsdruck bei High-Performance-Klienten und ein spannender Case: Wie würde sie mit Lindsey Vonn nach einer Verletzung umgehen?
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Draper Esprit PLC | 5.25 | -2.78% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Heimische Zahlenflut und anstehende NVIDIA-Bilanz: SMI wenig verändert -- DAX überspringt 25'000 Punkte -- KI-Hoffnungen treiben Asiens Börsen - Nikkei mit neuem RekordSMI-Anleger halten zur Wochenmitte zunächst die Füsse still. Am deutschen Aktienmarkt sind unterdessen leichte Gewinne zu sehen. An den Börsen in Asien dominierten am Mittwoch die Bullen.